RxDoctor Payments Data

Brittany Woodard, DO

Family Medicine · Duncan, SCNPI 1184277071

Payments from drug & device makers

$779in general payments, 2019–2025

Across 44 payments — averaging $17.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$114
  • AbbVie$102
  • Novo Nordisk$69
  • Exact Sciences$60
  • AstraZeneca$46
  • Dexcom, Inc.$44
  • plus $343 from 14 others

What the payments were for

  • Food & beverage$779100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$779 in reported general payments places this provider in the 55th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$28,599
Medicare patients
103
Services billed
285

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban47$33,745
OzempicSemaglutide23$31,019
TrulicityDulaglutide27$24,894
FarxigaDapagliflozin Propanediol23$24,006
JardianceEmpagliflozin23$21,090
MounjaroTirzepatide19$19,543
JanuviaSitagliptin Phosphate13$15,025
EntrestoSacubitril/Valsartan11$14,060
XareltoRivaroxaban21$12,898
Stiolto RespimatTiotropium Br/Olodaterol Hcl17$11,534
LinzessLinaclotide11$8,740
Repatha SureclickEvolocumab14$7,383
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,720
Albuterol Sulfate HfaAlbuterol Sulfate108$3,531
Duloxetine Hcl56$3,155

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$15$36,21660 claims
Boehringer IngelheimJardiance, Stiolto Respimat$15$32,62440 claims
Novo NordiskOzempic$69$31,01923 claims
AstraZenecaFarxiga$46$24,00623 claims
NovartisEntresto$114$14,06011 claims
AbbVieLinzess$102$8,74011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Duncan

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →